Wide assortment of products and services in the field of medical technology / devices primarily to publicly funded healthcare.
In the Medtech business area the subsidiaries offer products, solutions and services in medtech and home care. Customers include hospitals, care facilities and users. The business area is active in the Nordic countries, Central and Eastern Europe and to a limited extent, in Australia.
The Medtech business area has undergone strong growth during the year. Sales growth is largely the result of the Biomedica acquisition and 40 percent of Biomedica’s sales and earnings for the year were included in the Medtech business area. In the fourth quarter we received the first contracts to deliver our own medical device products to the markets in Central and Eastern Europe. The acquisition of the product portfolio in surgery and respiration from Wellspect HealthCare was integrated during the year in the subsidiary Mediplast, which entailed both extra work and costs. The product portfolio is a positive addition to our market offering and has enabled expansion into several new markets. In the Nordic markets, demand from health services was strong in Sweden, Norway and Denmark, while it continued to be somewhat weaker in Finland.
Sales growth for various types of assistive equipment for use in home care was strong and completely in line with the trends we see related to the increased need for eldercare. Welfare technology achieved a breakthrough in the market during the year and our solutions are favourably received by municipal and private operations in Norway. In the fourth quarter Oslo municipality awarded our Norwegian subsidiary Hepro a large contract in welfare technology for delivery over the next two to four years, with an order value of about NOK 120 million. We do not yet offer services and products in welfare technology in other markets, where the focus is instead on various types of assistive equipment for sitting, moving and, most of all, taking care of hygiene needs in the bathroom.
AddLife acquired us in February 2017. The integration has gone very smoothly and AddLife has lived up to what they said to us during the acquisition process. In my experience, we have freedom with responsibility and the Parent Company has a long-term perspective regarding our business. We now have stronger muscles, new partners and opportunities to enter new markets. I strongly believe that together with AddLife and the other Medtech companies we will continue on this successful path.
Wide assortment of products and services in the field of medical technology / devices primarily to publicly funded healthcare.
Geographical market: Central- and Eastern Europe
Segment: Cardiology, Surgery, Intensive Care, Oncology, Orthopaedics, Hygiene
Customer examples: Faculty Hospitals / Polyclinics / Cardiac Centers / Private Hospitals / Elderly Homes
Amount of employees: 280
Krabat develops, manufactures and markets high quality aids for children and youths. Krabat’s products are innovative, functional and esthetically attractive
Geographical market: Europe
Segment: Technical aids for children and youths
Customer examples: NAV (Norwegian Labour and Welfare Administration)
Amount of employees: 13
Sales of medical device equipment and supplies
Geographical market: Mainly the Nordic countries and the Netherlands
Segment: Surgery, thoracic medicine, neurology, intervention, bandages, anaesthesia/ICU, ENT, colostomy, enteral nutrition and home healthcare
Customer examples: Public as well as private healthcare
Amount of employees: 156
